Term ends Dec 9, 2037 · Low confidence
20-year base term ends Dec 9, 2037
Dec 9, 2017
Dec 9, 2037
Jun 1, 2021
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 9, 2017, when application PCT/US2017/065482, the earliest non-provisional in its chain, was filed (this one was filed Sep 20, 2019); a parent in its chain could not be resolved (the next row) | Dec 9, 2037 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,584,112, US 10,584,113, US 10,759,778, US 10,858,341, US 10,954,212, US 10,954,213, US 11,021,460) | resolves to Dec 9, 2037, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 9, 2037 | Low confidence |
This family
| US 10,584,113 | In force no later than Dec 2037 | no later than Dec 2037 |
| US 10,584,112 | In force no later than Dec 2037 | no later than Dec 2037 |
| US 10,759,778 | In force Dec 2037 | Dec 2037 |
| US 11,021,459 | this patent Dec 2037 | Dec 2037 |
| US 11,021,460 | In force Dec 2037 | Dec 2037 |
| US 10,954,212 | In force Dec 2037 | Dec 2037 |
| US 10,954,213 | In force Dec 2037 | Dec 2037 |
| US 10,858,341 | In force Dec 2037 | Dec 2037 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 23, 2020 Reel 53863, frame 377 | Mickle, Travis; Guenther, Sven; Chi, Guochen | Kempharm, Inc. | Assignment of Assignor's Interest |
| Feb 26, 2024 Reel 66679, frame 668 | Kempharm, Inc. | Zevra Therapeutics, Inc. | Change of Name |
| Apr 8, 2024 Reel 67040, frame 637 | Zevra Therapeutics, Inc. | Alter Domus (US) LLC | Security Interest |
| Mar 13, 2026 Reel 75080, frame 907 | Alter Domus (US) LLC | Zevra Therapeutics, Inc. | Release of Security Interest |
| Mar 25, 2026 Reel 74186, frame 531 | Zevra Therapeutics, Inc. | Commave Therapeutics S.A. | Assignment of Assignor's Interest |
| Mar 26, 2026 Reel 74195, frame 8 | Zevra Therapeutics, Inc. | Commave Therapeutics S.A. | Assignment of Assignor's Interest |
| Sep 11, 2026 Reel 75980, frame 787 | Commave Therapeutics S.A. | Truist Bank, As Administrative Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,584,112, US 10,584,113, US 10,759,778, US 10,858,341, US 10,954,212, US 10,954,213, US 11,021,460, ends no earlier than this term, so it caps nothing.